Vista Pharma Standalone September 2024 Net Sales at Rs 2.49 crore
Mon, Nov 25, 2024 12:27 PM

Vista Pharma Standalone September 2024 Net Sales at Rs 2.49 crore

A Flip by Shubhangi Gupta
Get it on Google Play
Reported Standalone quarterly numbers for Vista Pharmaceuticals are: Net Sales at Rs 2.49 crore in September 2024 down 28.1% from Rs. 3.47 crore in September 2023. Quarterly Net Loss at Rs. 0.97 crore in September 2024 up 51.78% from Rs. 2.02 crore in September 2023. EBITDA stands negative at Rs. 0.82 crore in September 2024 up 24.77% from Rs. 1.09 crore in September 2023.

More great flips

Will bribery allegations against Adani intensify FPI selling spree?

Will bribery allegations against Adani intensify FPI selling spree?

FPIs have been on a selling spree over the last one and a half months, withdrawing funds from Indian equities at an unprecedented pace and reversing their earlier purchasing streak. This sudden shift in FPI behaviour has weighed heavily on market sentiment marking the largest consecutive selling streak on record, amid concerns over bribery allegations against Adani Group.

Open Flip
Emkay cuts Nifty target to 25,000 but says earnings downgrades not alarming

Emkay cuts Nifty target to 25,000 but says earnings downgrades not alarming

Emkay Global has slashed its Nifty target by 4% to 25,000, citing a weak earnings season marked by sluggish consumption and deteriorating cash flows. However, the brokerage emphasised that while earnings trends have softened, they do not signal a cause for alarm. Despite the 10% correction in benchmark Nifty index since September 27, Emkay expects markets to “mark time” in the immediate future.

Open Flip
NSE, BSE face profit risk from proposal for clearing firms

NSE, BSE face profit risk from proposal for clearing firms

India's stock exchanges, NSE and BSE, may face profit declines if the SEBI implements proposed clearing house ownership changes. The regulator suggests diversifying ownership for market stability, impacting bourse earnings. Two options are proposed: a 100% sell-down or a phased reduction to 15% ownership. This adds to revenue pressures from stricter derivatives trading rules.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon